Paper23933259
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
Os A and 8 others. Cell Rep, 2013. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Papers, record 23933259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23933259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | Major topic |
| Th1 Cells | Major topic |
| Animals | |
| Antigen-Presenting Cells | |
| Cell Growth Processes | |
| Humans | |
| Lymphocyte Activation | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Transcriptome | |
| Tumor Microenvironment |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959570 | T cell-driven venetoclax resistance in chronic lymphocytic leukemia: in vivo preclinical activity of opaganib. | Front Immunol | 2026 | https://conductscience.org/library/papers/42959570 | PubMed |
| 42769825 | Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies. | Oncol Res | 2026 | https://conductscience.org/library/papers/42769825 | PubMed |
| 41741475 | Idiotype-specific CD4+ T cells chronically stimulate autoreactive B cells to develop into B lymphomas in mice. | Nat Commun | 2026 | https://conductscience.org/library/papers/41741475 | PubMed |
| 40906805 | PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40906805 | PubMed |
| 40571973 | Single-cell insights into the role of T cells in B-cell malignancies. | FEBS Lett | 2025 | https://conductscience.org/library/papers/40571973 | PubMed |
| 40313718 | Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40313718 | PubMed |
| 39941719 | Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941719 | PubMed |
| 39474602 | CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39474602 | PubMed |
| 38928031 | Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928031 | PubMed |
| 38877102 | Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs. | Leukemia | 2024 | https://conductscience.org/library/papers/38877102 | PubMed |
| 38606091 | CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression. | Front Oncol | 2024 | https://conductscience.org/library/papers/38606091 | PubMed |
| 37190234 | Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190234 | PubMed |
| 37100883 | Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation. | Leukemia | 2023 | https://conductscience.org/library/papers/37100883 | PubMed |
| 37064123 | NF-kB and the CLL microenvironment. | Front Oncol | 2023 | https://conductscience.org/library/papers/37064123 | PubMed |
| 36574293 | The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? | Blood Adv | 2023 | https://conductscience.org/library/papers/36574293 | PubMed |
| 36266281 | Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape. | Nat Commun | 2022 | https://conductscience.org/library/papers/36266281 | PubMed |
| 35883619 | CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints. | Cells | 2022 | https://conductscience.org/library/papers/35883619 | PubMed |
| 35804862 | In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35804862 | PubMed |
| 35655388 | T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation. | Br J Haematol | 2022 | https://conductscience.org/library/papers/35655388 | PubMed |
| 35309250 | B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells. | Explor Target Antitumor Ther | 2022 | https://conductscience.org/library/papers/35309250 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD40LG | 959 | PubTator's text mining | https://conductscience.org/library/genes/959 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE48268 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23933259
GET https://conductscience.org/api/papers/v1/23933259/cited_by?page=2